Skip to content
Oxybenzone
Shade Uvaguard (oxybenzone) is a small molecule pharmaceutical. Oxybenzone was first approved as Shade uvaguard on 1992-12-07. It is used to treat photosensitivity disorders in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Avobenzone
+
Octinoxate
+
Oxybenzone
Tradename
Company
Number
Date
Products
SHADE UVAGUARDBayerN-020045 DISCN1992-12-07
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
aloe up natural lip ice sunscreenOTC monograph not final2023-06-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
photosensitivity disorders—D010787L57.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXYBENZONE
INNoxybenzone
Description
Oxybenzone is a hydroxybenzophenone that is benzophenone which is substituted at the 2- and 4-positions of one of the benzene rings by hydroxy and methoxy groups respectively. It has a role as a dermatologic drug, a protective agent, an ultraviolet filter, a xenobiotic and an environmental contaminant. It is a hydroxybenzophenone and a monomethoxybenzene.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1ccc(C(=O)c2ccccc2)c(O)c1
Identifiers
PDB—
CAS-ID131-57-7
RxCUI32673
ChEMBL IDCHEMBL1625
ChEBI ID34283
PubChem CID4632
DrugBankDB01428
UNII ID95OOS7VE0Y (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 629 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
24 adverse events reported
View more details